Abstract
Introduction
The previously published European Association of Nuclear Medicine (EANM) paediatric dosage card recommends 70 MBq F-18 or F-18 Fluoro-2-Deoxyglucose (F-18-FDG) as the “minimum recommended activity”.
Discussion
Two recent publications demonstrate that when utilising F-18-labelled radiopharmaceuticals the administration of lower activities for small children is possible without losing image quality.
Conclusion
In the light of these findings the EANM dosimetry and paediatrics committee have decided to reduce the value for the “minimum recommended activity” for both F-18 and F-18-FDG to 26 MBq for 2D- and 14 MBq for 3D-acquisitions.
References
Holm S, Borgwardt L, Loft A, Graff J, Law I, Hojgaard L. Paediatric doses—a critical appraisal of the EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2007;34(11):1713–8.
Warbey VS, Schleyer PJ, Barrington SF, O’Doherty MJ. The new EANM paediatric dosage card—does it conform to ALARA for PET/CT. Eur J Nucl Med Mol Imaging. 2007;34(11):1881–82.
Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F, EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2007;34(5):796–8
ICRP Publication 60. 1990 Recommendations of the ICRP. Annals of ICRP 1992 21:1–3; Pergamon Press, Oxford.
ICRP Publication 80. Radiation dose to patients from radiopharmaceuticals. Annals of the ICRP 1999 28; Pergamon Press, Oxford.
Bartenstein P, Asenbaum S, Catafau A, Halldin C, Pilowski L, Pupi A, et al. Brain imaging using [18F]FDG. 2001. http://www.eanm.org/scientific_info/guidelines/gl_neuro_img_fdg.php?navId=54.
Schober O, Heindel W. PET-CT. RRR (Referenz Reihe Radiologie) Georg Thieme Verlag Stuttgart; 2008, p 80.
Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, Kolinska J, Gwillst J. A radiopharmaceutical schedule for imaging in paediatrics. Eur J Nucl Med. 1990;17:127–29.
Disclaimer
The European Association has written and approved guidelines to promote the use of nuclear medicine procedures with high quality. These general recommendations cannot be applied to all patients in all practice settings. The guidelines should not be deemed inclusive of all proper procedures and exclusive of other procedures reasonably directed to obtaining the same results. The spectrum of patients seen in a specialised practice setting may be different than a spectrum usually seen in a more general setting. The appropriateness of a procedure will depend in part on the prevalence of disease in the patient population. In addition resources available to care for patients may vary greatly from one European country or one medical facility to another. For these reasons, guidelines cannot be rigidly applied.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00259-008-0952-5
Rights and permissions
About this article
Cite this article
Lassmann, M., Biassoni, L., Monsieurs, M. et al. The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging 35, 1666–1668 (2008). https://doi.org/10.1007/s00259-008-0799-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-008-0799-9